Evaluating the anti-neuropathic effects of the thymol-loaded nanofibrous scaffold in a rat model of spinal cord injury

(2025) Evaluating the anti-neuropathic effects of the thymol-loaded nanofibrous scaffold in a rat model of spinal cord injury. Frontiers in pharmacology. p. 1507397. ISSN 1663-9812 (Print) 1663-9812 (Electronic) 1663-9812 (Linking)

Full text not available from this repository.

Abstract

BACKGROUND: Spinal cord injury (SCI) is a debilitating condition characterized by partial or complete loss of motor and sensory function caused by mechanical trauma to the spinal cord. Novel therapeutic approaches are continuously explored to enhance spinal cord regeneration and functional recovery. PURPOSE: In this study, we investigated the efficacy of the poly(vinyl alcohol) and chitosan (PVA/CS) scaffold loaded with different thymol concentrations (5, 10, and 15 wt) in a rat compression model for SCI treatment compare to other (e.g., thymol and scaffold) control groups. RESULTS AND DISCUSSION: The thymol-loaded scaffold exhibited a smooth surface and a three-dimensional nanofibrous structure with nanoscale diameter. The conducted analyses verified the successful incorporation of thymol into the scaffold and its high water absorption, porosity, and wettability attributes. Behavioral assessment of functional recovery showed improving sensory and locomotor impairment. Furthermore, histopathological examinations indicated the regenerative potential of the thymol-loaded nanofiber scaffold, by neuronal survival. CONCLUSION: Therefore, these findings suggest that the thymol-loaded nanofibrous scaffolds have promising pharmacological activities for alleviating neuropathic pain and addressing complications induced by SCI.

Item Type: Article
Keywords: chitosan motor activity neuropathic pain poly(vinyl alcohol) spinal cord injury thymol-scaffold commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Page Range: p. 1507397
Journal or Publication Title: Frontiers in pharmacology
Journal Index: Pubmed
Volume: 16
Identification Number: https://doi.org/10.3389/fphar.2025.1507397
ISSN: 1663-9812 (Print) 1663-9812 (Electronic) 1663-9812 (Linking)
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/31352

Actions (login required)

View Item View Item